Results 21 to 30 of about 4,992,809 (126)

Blastic plasmacytoid dendritic cell neoplasm of skin, a rare dermatohematologic malignancy—A case report

Clinical Case Reports
Key Clinical Message Blastic plasmacytoid dendritic cell neoplasm is a rare hematologic malignancy and appropriate diagnosis encounters difficulties in both clinical and pathologic aspects.
Ramtin Edjtemaei, Alireza Ghanadan, Fereshte Ameli   +2 more
doaj   +2 more sources

Blastic Plasmacytoid Dendritic Cell Neoplasm

Current Hematologic Malignancy Reports, 2018
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare malignancy derived from plasmacyoid dendritic cells whose biology, clinical features, and treatment options are increasingly better understood.TCF4 is a master regulator that drives donwstream transcriptional programs in BPDCN.
Manoj Ponadka Rai, Prabhjot Singh Bedi, Samanjit Kaur Kandola, Shilpa Kavuturu, Rashi Singhal   +4 more
  +7 more sources

Blastic plasmacytoid dendritic cell neoplasm in a young patient [PDF]

, 2021
Blastic plasmacytoid dendritic cell neoplasm is a rare hematologic neoplasm originating from plasmacytoid dendritic cell precursors that has an aggressive disease course with typically poor prognosis.
Harker, David, Li, Jeffrey N, Dominguez, Arturo, Vandergriff, Travis   +3 more
core   +1 more source

A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who underwent allogeneic stem cell transplantation: a case report

Journal of Medical Case Reports, 2021
Background Blastic plasmacytoid dendritic cell neoplasm represents a rare type of hematologic malignancy that often manifests itself through various skin lesions. It commonly affects the elderly male population.
Fateme Salemi, Seyed Mohammad Reza Mortazavizadeh, Seyyedmohammadsadeq Mirmoeeni, Amirhossein Azari Jafari, Farid Kosari, Seyed Sina Naghibi Irvani   +5 more
doaj   +1 more source

Pathomorphological and clinical characteristics of blastic plasmocytoid dendritic cell neoplasm. Case report

Терапевтический архив, 2022
The paper reveals the 5 cases date about blastic plasmacytoid dendritic cell neoplasm. The presented information demonstrates morphological, immunohistochemical data and clinical manifestations.
Andrei A. Sherstnev, Alla M. Kovrigina, Tatiana I. Solovyova, Tatiana N. Moiseeva   +3 more
doaj   +1 more source

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells

Nature Communications, 2022
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematologic malignancy derived from the precursors of plasmacytoid dendritic cells.
Tianyu Cai, Agnès Gouble, Kathryn L. Black, Anna Skwarska, Ammar S. Naqvi, Deanne Taylor, Ming Zhao, Qi Yuan, Mayumi Sugita, Qi Zhang, Roman Galetto, Stéphanie Filipe, Antonio Cavazos, Lina Han, Vinitha Kuruvilla, Helen Ma, Connie Weng, Chang-Gong Liu, Xiuping Liu, Sergej Konoplev, Jun Gu, Guilin Tang, Xiaoping Su, Gheath Al-Atrash, Stefan Ciurea, Sattva S. Neelapu, Andrew A. Lane, Hagop Kantarjian, Monica L. Guzman, Naveen Pemmaraju, Julianne Smith, Andrei Thomas-Tikhonenko, Marina Konopleva   +32 more
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCN

Hematology, Transfusion and Cell Therapy, 2023
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with an aggressive clinical course and poor prognosis. BPDCN is most often characterized by its presentation with cutaneous lesions which are often asymptomatic, can be
Hanan Hamed
doaj   +1 more source

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms

eJHaem, 2022
This report highlights the value of flow cytometry analysis, particularly in the setting of myeloproliferative neoplasms showing features of progression, as neoplastic plasmacytoid dendritic cell (PDC) proliferations may be present, representing either a
Siba El Hussein, Mariko Yabe, Wei Wang, Naveen Pemmaraju, Sanam Loghavi, Fatima Zahra Jelloul, Hong Fang, L. Jeffrey Medeiros, W. Richard Burack, Andrew G. Evans, Jane L. Liesveld, John M. Bennett   +11 more
doaj   +1 more source

Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

, 2014
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs).
Pileri A. Jr, Gazzola A, Rossi M, Cerroni L, FACCHETTI, Fabio, Arpinati M, Santucci M, Fuligni F, for the AIRC 5xMille consortium ‘Genetics driven targeted management of lymphoid malignancies’, the Italian Registry on Blastic Plasmacytoid Dendritic Cell Neoplasm, Agostinelli C, Sapienza MR, GIBELLINI, Davide, Gibellini D, Laginestra MA, Mannu C, Maeda T, Croce CM, Tripodo C, Pileri SA, Righi S, Ulbar F, Melle F, Pagano L, Paulli M, Ricci F, Piccaluga PP, Facchetti F, Mancini M, Pimpinelli N   +29 more
core   +3 more sources

MRD IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

Hematology, Transfusion and Cell Therapy, 2022
Objective: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare disease with an aggressive course. Plasmacytoid dendritic cells (PDCs) are a component of the innate immune response: they secrete large amounts of type I interferons ...
Aleksandra Palladina, Alexander Popa, Timur Valiev, Nikolay Tupitsyn   +3 more
doaj   +1 more source